Early Intervention in Preterm Infants: Short and Long Term Developmental Outcome After a Parental Training Program

Early Intervention in Preterm Infants: Effects of a Parental Training Program on Neonatal Brain Development, Visual Functions and Neurobehavioral Outcome

Preterm infants, during their stay in the Neonatal Intensive Care Unit (NICU), face a period of stressful environment, which may negatively impact early brain development and subsequent neurobehavioral outcomes. This study aims to assess the effectiveness of training parents in reducing stressful experiences early in life and in enhancing brain development and long term developmental outcomes.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Very preterm birth is associated with motor, cognitive and behavioral problems.

Micro-structural brain abnormalities, even in the absence of focal lesions, have been documented by neuroimaging studies in preterm infants at term corrected age and later in childhood. These alterations in brain maturation occurring during the neonatal period may be implicated in long-term neurobehavioral disorders later experienced by preterm babies.

However, there is increasing evidence that also negative environmental factors (intensive care, excessive sensory stimulation, paucity of parental contact etc.) can affect later outcomes.

Potential benefits of early dyadic interaction and preterm baby massage in reducing the effects of the NICU stressor environment have been demonstrated. More recently, few studies have investigated visual function in preterm infants focusing on the potential role of early visual interaction to enhance attention and improve later neurodevelopment.

The role of early intervention strategies to improve neurodevelopment has been recently emphasized.

Early intervention programs based on the concept of "individualized care" have proved to be effective in promoting brain maturation and neurodevelopmental outcome. In this context, early interventions as the Mother Infant Transaction Program (MITP) and the Premie Start, both targeting parenting, have the greatest potential to have sustained effects on child development.

In addition, recent studies have shown that exposure to stressful events in the neonatal period can cause epigenetic modifications in children born preterm; in particular alteration of serotonergic tone was observed, associated with methylation of the serotonin transporter gene, which could be implicated in the etiology of behavioral disorders observed in these children. In animal models these epigenetic effects appear to be influenced by maternal care that can epigenetically modulate the offsprings' stress response.

Study Type

Interventional

Enrollment (Actual)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Milan, Italy, 20122
        • NICU, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

5 months to 6 months (CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Gestational age between 25+0 and 29+6 weeks

Exclusion Criteria:

  • major brain lesions as documented by cranial ultrasound (intraventricular hemorrhage > 2 grade, cystic periventricular leukomalacia)
  • neurosensorial deficits (retinopathy of prematurity > stage 2)
  • genetic syndromes and/or major congenital malformations
  • major neonatal comorbidities

Mothers are selected according to the following inclusion criteria: age over 18 years, good comprehension of Italian language, no obvious cognitive impairments or psychiatric disorders, no drug addiction and no single-parent families.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SUPPORTIVE_CARE
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Early Intervention

The early intervention program is delivered during the NICU stay, according to the MITP and Premie Start Protocol, in order to train parents to: recognize signs of infant stress and alert-available behavior to promote mother-infant interaction; adopt principles of graded stimulation; optimize interactions and avoid overwhelming infants through facilitation strategies (for example, engage and support the visual attention of the newborn). The program is held in eight main sessions and one additional post-discharge session.

In addition parents are trained and invited to daily promote preterm baby massage therapy and visual attention according to a detailed protocol.

NO_INTERVENTION: Standard Care
Standard Care according to NICU protocols including Kangaroo Mother Care, nesting and minimal handling

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Neonatal Visual Assessment Battery to evaluate visual function
Time Frame: 40 weeks postmenstrual age
Neonatal Visual Function is assessed using the Visual Assessment Battery developed by Ricci et al. The assessment evaluates the following items: Ocular spontaneous motility, ability to fix and follow a target, reaction to colour, visual acuity and visual attention at distance. Each item is scored as normal (score 0) or abnormal (score 1). The global score is then calculated as the sum of all the individual items, as designed by the authors.
40 weeks postmenstrual age
Neonatal Behavior
Time Frame: 2 months corrected age
Neonatal behavior is assessed using the Neonatal Behavior Assessment Scale that evaluates: habituation, social-interactive, motor system, state organization and regulation, autonomic system, reflexes.
2 months corrected age

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Brain development
Time Frame: 40 weeks postmenstrual age
Conventional and advanced MRI
40 weeks postmenstrual age
Developmental outcome
Time Frame: 24 months corrected age
Children development is assessed using the Bayley Scales of Infant and Toddlers (Third edition) - including: cognitive, motor, language, social-emotional and adaptive behavior)
24 months corrected age
Epigenetic changes
Time Frame: up to 48 weeks gestational age
epigenetic analysis is performed at birth on a cord blood sample (0.5 ml) and at hospital discharge on a peripheral blood sample (0.5 ml) collected according routine clinical procedures
up to 48 weeks gestational age
overall duration of hospitalisation
Time Frame: up to 48 weeks gestational age
number of days from admission to home discharge from NICU
up to 48 weeks gestational age
Weight (in grams) at 40 weeks postmenstrual age
Time Frame: 40 week gestational age
40 week gestational age
Length(in centimeters) at 40 weeks postmenstrual age
Time Frame: 40 week gestational age
40 week gestational age
Head circumference (in centimeters) at 40 weeks postmenstrual age
Time Frame: 40 week gestational age
40 week gestational age
Acquisition of full oral feeding
Time Frame: up to 48 weeks gestational age
Postmenstrual age at the acquisition of full oral feeding
up to 48 weeks gestational age
Feeding with Human milk
Time Frame: up to 40 weeks gestational age
Feeding with human milk at 40 weeks postmenstrual age (yes or no)
up to 40 weeks gestational age
Neurodevelopmental outcome
Time Frame: 5-6 years of age

Children neurodevelopment is assessed using the Griffiths Development Scales (GMDS).

Scores range from 50 to 150 General quotient mean 100 SD 12, sub scales mean 100 SD 16 Higher scores mean a better outcome

5-6 years of age
Behavioral outcome
Time Frame: 5-6 years of age
Children behavior is assessed using the Child Behavior Checklist. A T score above 70 is considered to be in the clinical range, a T score between 65 an 70 is considered borderline while a T score below 65 is considered normal
5-6 years of age
Neuromotor outcome
Time Frame: 5-6 years of age

Children neuromotor is assessed using the Movement Assessment Battery for Children (Movement ABC).

A score above 67 is considered to be in the normal range, a score between 57 an 67 is considered borderline while a score below 56 is considered pathological

5-6 years of age
Attention outcome
Time Frame: 5-6 years of age

Child attention abilities is assessed using the Early Childhood Attention Battery (ECAB).

Scaled scores range from 1 to 19. Lower scores indicate worst outcome

5-6 years of age
L1 promoter methylation levels on buccal swab
Time Frame: 5-6 years of age
epigenetic analysis - L1 promoter methylation (Percent) assessment is performed on a buccal swab collected at follow-up assessment at 5-6 years.
5-6 years of age

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Monica Fumagalli, MD, Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2014

Primary Completion (ACTUAL)

April 1, 2017

Study Completion (ACTUAL)

January 1, 2023

Study Registration Dates

First Submitted

November 16, 2016

First Submitted That Met QC Criteria

December 2, 2016

First Posted (ESTIMATE)

December 6, 2016

Study Record Updates

Last Update Posted (ACTUAL)

February 10, 2023

Last Update Submitted That Met QC Criteria

February 9, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

individual patient consent would be required according to the EU GDPR and Italian regulations

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Premature Birth

Clinical Trials on Early Intervention

3
Subscribe